Musculoskeletal defects associated with myosin heavy chain‐embryonic loss of function are mediated by the YAP signaling pathway
Anushree Bharadwaj(Regional Centre for Biotechnology), Sam J. Mathew(Regional Centre for Biotechnology)
Cited by 12
Related Papers
SPRY2 is a novel MET interactor that regulates metastatic potential and differentiation in rhabdomyosarcoma
|Cell Death and Disease|2018|30